Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-067906
Filing Date
2025-03-31
Accepted
2025-03-31 08:39:00
Documents
3
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 6-K d939120d6k.htm 6-K 9242
2 EX-99.1 d939120dex991.htm EX-99.1 8435
3 GRAPHIC g939120dsp4.jpg GRAPHIC 10306
  Complete submission text file 0001193125-25-067906.txt   27818
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 25789101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)